← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

EVP and General Counsel Paul A Mahon sold $4.7M of United Therapeutics Corporation

Sold$4,671,399
$562.82Price
8,300Shares
−16%Stake

What UTHR did after the filing

Filed May 21Copier in May 22
The stock from Fri, May 22 open, $567.30
−2.3%
S&P 500, same days
−0.1%

Measured over 30 trading days, to the Jul 8 close.

Traded Thu, May 21. Filed Thu, May 21, 4:33 PM ET, after the close. Returns use the May 22 open and the Jul 8 close. Not investment advice.